Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis
Evan B. Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 5, pp. 426-445
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Hepatitis C
Marianne Martinello, Sunil S. Solomon, Norah A. Terrault, et al.
The Lancet (2023) Vol. 402, Iss. 10407, pp. 1085-1096
Closed Access | Times Cited: 80
Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020
W. Thompson, Hasan Symum, Amy L. Sandul, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 32, pp. 1011-1017
Open Access | Times Cited: 77
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Alison D. Marshall, Alex Willing, Abe Kairouz, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 4, pp. 366-382
Closed Access | Times Cited: 31
Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine
Andrew H. Talal, Marianthi Markatou, Anran Liu, et al.
JAMA (2024) Vol. 331, Iss. 16, pp. 1369-1369
Closed Access | Times Cited: 23
A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study
Yumi Sheehan, Evan B. Cunningham, Amanda Cochrane, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 635-644
Closed Access | Times Cited: 30
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study
Jason Grebely, Rosie Gilliver, Tony McNaughton, et al.
International Journal of Drug Policy (2023) Vol. 114, pp. 103982-103982
Open Access | Times Cited: 24
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis
Evan B. Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103917-103917
Closed Access | Times Cited: 35
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review
Beth Catlett, Behzad Hajarizadeh, Evan B. Cunningham, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 6, pp. 1005-1021
Closed Access | Times Cited: 32
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study
Heather Valerio, Maryam Alavi, Anna Conway, et al.
International Journal of Drug Policy (2022) Vol. 105, pp. 103706-103706
Closed Access | Times Cited: 25
Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations
Meghan D. Morris, Claire McDonell, Annie Luetkemeyer, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2338792-e2338792
Open Access | Times Cited: 15
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review
Behzad Hajarizadeh, Abe Kairouz, Sophie Ottaviano, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 12, pp. e1885-e1898
Open Access | Times Cited: 14
Reducing barriers to the hepatitis C care cascade in prison via point‐of‐care RNA testing: a qualitative exploration of men in prison using an integrated framework
Lise Lafferty, Yumi Sheehan, Amanda Cochrane, et al.
Addiction (2023) Vol. 118, Iss. 6, pp. 1153-1160
Open Access | Times Cited: 13
Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study
Erin M. McCartney, Lucy Ralton, Joshua Dawe, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 4, pp. 965-973
Closed Access | Times Cited: 5
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?
Jason Grebely, Susan Matthews, Louise Causer, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 3, pp. 177-191
Closed Access | Times Cited: 4
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot
Nigel Carrington, Anna Conway, Jason Grebely, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Implementing a new HCV model of care for people who use drugs
Andrea Herranz, Camila A. Picchio, Aina Nicolàs, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101145-101145
Open Access | Times Cited: 4
Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain)
Pablo Parada Vázquez, Santiago Pérez-Cachafeiro, Belén Castiñeira Domínguez, et al.
Gastroenterología y Hepatología (English Edition) (2025) Vol. 48, Iss. 1, pp. 502226-502226
Closed Access
Enhancing hepatitis C virus testing, linkage to care and treatment commencement in hospitals: a systematic review and meta-analysis
R. H. Mathews, Chen Shen, Michael W. Traeger, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 2
Open Access
The urgent need for implementation science to achieve hepatitis C elimination
Guillaume Fontaine, Natalie Taylor, Julie Bruneau, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study
Colleen A McGourty, Diana Ung, Mackenzie Clark, et al.
International Journal of Drug Policy (2025) Vol. 139, pp. 104768-104768
Open Access
Gender-based factors associated with hepatitis C testing in people who inject drugs: results from the French COSINUS cohort
Ilhame Anwar, Aissatou Faye, Cécile Donadille, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e091707-e091707
Open Access
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia
Shane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
International Journal of Drug Policy (2025) Vol. 139, pp. 104790-104790
Open Access
“It's not just running the test”: Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in Australia
Grace K Burton-McKeich, Lise Lafferty, Carla Treloar, et al.
International Journal of Drug Policy (2025) Vol. 140, pp. 104800-104800
Open Access
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility
Michael MacIsaac, Bradley Whitton, Jenine Anderson, et al.
International Journal of Drug Policy (2024) Vol. 125, pp. 104317-104317
Closed Access | Times Cited: 3
Point-of-care testing for hepatitis C infection: A critical building block for the foundation to achieve elimination
Jason Grebely
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top